Approved Patient Labeling
Found 5 free book(s)
FDA-Approved Patient Labeling NEXPLANON (etonogestrel ...
www.organon.com1 FDA-Approved Patient Labeling NEXPLANON (etonogestrel implant) Radiopaque Subdermal Use Only NEXPLANON does not protect against HIV infection (the virus that causes AIDS) or other sexually transmitted diseases. Read this Patient Information leaflet carefully before you decide if NEXPLANON is right for you.
HIGHLIGHTS OF PRESCRIBING INFORMATION …
www.merck.comSee 17 for PATIENT COUNSELING INFORMATION and FDA-approved patient labeling. Revised: 10/2016 FULL PRESCRIBING INFORMATION: CONTENTS* 1 INDICATIONS AND USAGE 2 DOSAGE AND ADMINISTRATION 2.1 Important Administration Instructions 2.2 DosingRecommendations in Adults 2.3 Preparation and Administration 3 DOSAGE FORMS …
HIGHLIGHTS OF PRESCRIBING INFORMATION …
media.allergan.comand FDA-approved patient labeling. Revised: 03/2021 FULL PRESCRIBING INFORMATION: CONTENTS* 1 INDICATIONS AND USAGE 2 DOSAGE AND ADMINISTRATION 2.1 Recommended Dosage 2.2 Dosage Modifications 3 DOSAGE FORMS AND STRENGTHS 4 CONTRAINDICATIONS 6 ADVERSE REACTIONS 6.1 Clinical Trials Experience ...
PACKAGING AND LABELING GUIDE - Oregon
www.oregon.govconsumer, “containers.”patient, or designated primary caregiver to get packages and labels approved through the OLCC pre-approval process (see Pre-approval Process Section).1 “Ultimate sale” means the final sale from a retail location or dispensary to a consumer, patient, or designated primary caregiver.
Brovana Approved Labeling Text
www.brovana.comacting beta2-agonist and instruct the patient how it should be used. Increasing inhaled beta2-agonist use is a signal of deteriorating disease for which prompt medical attention is indicated. COPD may deteriorate acutely over a period of hours or chronically over several days or longer.